Search results for: 'asia pharmaceutical ingredients market'

05 Apr 2023  |  Asia Pacific  |  Market Outlook

Asia-Pacific Pharmaceutical Industry Outlook, 2023

Disruptive Technology Adoption and Outsourcing Growth is Advancing Innovation in the Pharmaceutical Industry

Infographics

×

Asia-Pacific’s pharmaceutical market is forecast to record 4.2% growth from 2022 to 2027, with China and Japan dominating the market in terms of value. Generics dominate the regional markets based on volume, directly impacting innovator molecule uptake. Nevertheless, Asia-Pacific is establishing itself as a global innovation hub, with China, Japan,...

The cosmetics and personal care color ingredients industry is undergoing a transition driven by evolving consumer preferences, regulatory changes, and continuous formulation innovation. Demand is shifting toward high-performance pigments that deliver enhanced color intensity, long-lasting wear, improved stability, and multifunctional benefits such ...

31 Mar 2025  |  Global  |  Market Research

Biotic Ingredients Industry, Global, 2025–2030

Research and Product Development Advances in Human Milk Oligosaccharides and Postbiotics are Driving Transformational Growth

Infographics

×

The biotics industry has witnessed a remarkable transformation in recent years, driven by rapid innovations in each biotics segment: probiotics, prebiotics, and postbiotics.Consumer awareness of probiotic benefits, innovations, and favorable regulatory developments in Europe drive the segment’s growth. Increasing consumer awareness of the therapeut...

The personal care ingredients market is entering a decisive transformation phase, driven by accelerating regulatory pressure, rapid advances in biotechnology and digital innovation, shifting consumer expectations, and increasing supply chain volatility. Traditional ingredient development models—largely dependent on linear sourcing, incremental refo...

The research assesses growth opportunities for medical food ingredients across key therapeutic applications and regional markets. Medical foods, also referred to as Foods for Special Medical Purposes (FSMPs), occupy a distinct regulatory and commercial position between pharmaceuticals and nutraceuticals, addressing disease-specific nutritional requ...

This outlook identifies the trends shaping the global pharmaceutical landscape. The growth of the global pharmaceutical industry will plateau in 2023 due to a slowdown of the biologics segment as a result of a decrease in the uptake of COVID-19 vaccines and therapeutics. Market growth will be low in the United States and Europe and highest in the A...

Continuous manufacturing (CM) is a method for manufacturing end-to-end pharmaceutical products on a single, uninterrupted production line. While batch manufacturing requires transporting, testing, and refeeding materials from one process to the next, continuous processes execute all testing, feeding, and processing inline at a single manufacturing ...

An upcycled ingredient is an ingredient produced by the valorization of byproducts obtained from processes along the agro-food industry value chain that can re-enter the food value chain as part of a new product. In practice, the food system can get more out of less by creating two or more products out of resources that formerly produced only o...

This growth opportunity analytics of botanical ingredients provides qualitative and quantitative analyses of botanical ingredients used across the nutraceutical and personal care and cosmetic industry. Major botanical ingredient types covered under the nutraceutical segment include ashwagandha, boswellia serrata, ginkgo biloba, elderberry, ginseng,...